Clopidogrel Bisulfate and Aspirin
- Generic Name
- Clopidogrel Bisulfate and Aspirin
- Indication
用于已经服用氯吡格雷和阿司匹林的急性冠状动脉综合征成年患者的动脉粥样硬化血栓形成的患者。预防非ST段抬高的急性冠脉综合征（不稳定型心绞痛/非Q波MI）患者的动脉粥样硬化血栓形成事件；有资格进行溶栓治疗的药物治疗患者的ST段抬高急性心肌梗死。
Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects
Phase 1
Completed
- Conditions
- Acute Coronary Syndrome
- Interventions
- First Posted Date
- 2012-08-03
- Last Posted Date
- 2012-08-03
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT01657071
- Locations
- 🇰🇷
Yuhan Corporation, Seoul, Korea, Republic of
Comparative Pharmacokinetics of YH14659
Phase 1
Completed
- Conditions
- Acute Coronary Syndrome
- Interventions
- First Posted Date
- 2011-08-23
- Last Posted Date
- 2012-01-09
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 44
- Registration Number
- NCT01422109
- Locations
- 🇰🇷
Yuhan Corporation, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath